DCK and neoplasm: The major mechanisms of the action of gemcitabine are abrogating DNA synthesis and self-potentiation by activating deoxycytidine kinase and caspase signaling, leading to apoptosis [46], which has modified tumor microenvironment and ultimately influenced the APT signal.